Skip to main content
OpenTrials

Clinical trial condition

Diffuse Large B-cell Lymphoma

Explore clinical trials studying Diffuse Large B-cell Lymphoma. Study availability and eligibility vary by location and protocol.

217 public trials 53 recruiting studies
Refine in advanced search Browse all conditions

Diffuse Large B-cell Lymphoma trial results

Completed

Prognostic Value of Clinical and Biological Factors in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma

NCT01369784

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Hospital de Elda Elda, Alicante, Spain
  • H. U. Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Clinic i Provincial Barcelona, Spain
  • Hospital del Mar Barcelona, Spain
View all 56 locations
View Trial Details
Completed

Combination of SAR3419 and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT01470456

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Investigational Site Number 040002 Graz, Austria
  • Investigational Site Number 250004 Créteil, France
  • Investigational Site Number 250009 Dijon, France
  • Investigational Site Number 250006 Lille, France
View all 13 locations
View Trial Details
Completed

Study to Learn if 200mg Test Drug (Fostamatinib) Helps People With Large B-Cell Lymphoma,a Type of Blood Cancer

NCT01499303

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Research Site Huntsville, Alabama, United States
  • Research Site Denver, Colorado, United States
  • Research Site New Haven, Connecticut, United States
  • Research Site Sarasota, Florida, United States
View all 21 locations
View Trial Details

Related conditions